The Journal of Urology
Volume 177, Issue 4 , Pages 1303-1306 , April 2007

Prostate Cancer Screening and Disease Management: How Screening May Have an Unintended Effect on Survival and Mortality—The Camel’s Nose Effect

  • Rhonda M. Walsh

      Affiliations

    • Corresponding Author InformationCorrespondence: Department of Urology, UTHSCSA, 7703 Floyd Curl Drive, San Antonio, Texas 78229 (telephone: 210-567-5643: FAX: 210-567-6868).
  • ,
  • Ian M. Thompson

Received 24 July 2006

References 

  1. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:917
  2. Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, et al. Prostate-specific antigen best practice policy–part I: early detection and diagnosis of prostate cancer. Urology. 2001;57:217
  3. Derweesh IH, Kupelian PA, Zippe C, Levin HS, Brainard J, Magi-Galluzzi C, et al. Continuing trends in pathological stage migration in radical prostatectomy specimens. Urol Oncol. 2004;22:300
  4. Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, et al. Cancer surveillance series: interpreting trends in prostate cancer—part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst. 1999;91:1017
  5. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21:273S
  6. Schroder FH, Raaijmakers R, Postma R, vanderKwast TH, Roobol MJ. 4-year prostate specific antigen progression and diagnosis of prostate cancer in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam. J Urol. 2005;174:489
  7. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med. 2004;350:2239
  8. Thompson IM, Ankerst DP, Chi C, Lucia MS, Goodman PJ, Crowley JJ, et al. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. JAMA. 2005;294:66
  9. Jamal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101:3
  10. Brenner H, Arndt V. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis. J Clin Oncol. 2005;23:441
  11. American Cancer Society. Cancer Facts and Figures 2006. Atlanta: American Cancer Society; 2006;
  12. Earle CC, Burstein HJ, Winer EP, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003;21:1447
  13. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?. JAMA. 2003;289:1414
  14. Xu KT, Borders TF. Gender, health, and physician visits among adults in the United States. Am J Public Health. 2003;93:1076
  15. Lethbridge-Cejku M, Vickerie J. Summary Health Statistics for U.S. Adults: National Health Interview Survey. 2003;Available at www.cdc.gov/men/az.htm#stats. Accessed July 24, 2006.
  16. Staessen JA, Gasowski J, Wang JG, Thijs L, DenHond E, Boissel JP, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355:865
  17. Akhtar S, Barash PG. Perioperative use of beta-blockers: past, present, and future. Int Anesthesiol Clin. 2002;40:133
  18. Lindholm H, Carlberg B, Samuelsson O. Should β-blockers remain first choice in the treatment of primary hypertension? (A meta-analysis). Lancet. 2005;366:1545

 Study received institutional review board approval.See Editorial on page 1225.

PII: S0022-5347(06)03115-6

doi: 10.1016/j.juro.2006.11.064

The Journal of Urology
Volume 177, Issue 4 , Pages 1303-1306 , April 2007